Replies to post #243325 on Biotech Values

[DewDiligence]

ABBV 3Q22 Mavyret sales=$383M, -4% QoQ, -10% YoY:

https://news.abbvie.com/news/press-releases/abbvie-reports-third-quarter-2022-financial-results.htm

The geographic breakdown was: US $190M; ex-US $193M.